CRISPR Therapeutics AG (CRSP) Current Taxes (2016 - 2025)
Historic Current Taxes for CRISPR Therapeutics AG (CRSP) over the last 11 years, with Q3 2025 value amounting to $3.4 million.
- CRISPR Therapeutics AG's Current Taxes rose 30883.05% to $3.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $3.4 million, marking a year-over-year increase of 30883.05%. This contributed to the annual value of $451000.0 for FY2024, which is 296.8% up from last year.
- Per CRISPR Therapeutics AG's latest filing, its Current Taxes stood at $3.4 million for Q3 2025, which was up 30883.05% from $715000.0 recorded in Q2 2025.
- In the past 5 years, CRISPR Therapeutics AG's Current Taxes registered a high of $4.5 million during Q2 2021, and its lowest value of $135000.0 during Q4 2022.
- For the 5-year period, CRISPR Therapeutics AG's Current Taxes averaged around $1.7 million, with its median value being $838000.0 (2024).
- Its Current Taxes has fluctuated over the past 5 years, first skyrocketed by 108169.01% in 2021, then plummeted by 9588.01% in 2023.
- CRISPR Therapeutics AG's Current Taxes (Quarter) stood at $724000.0 in 2021, then crashed by 81.35% to $135000.0 in 2022, then skyrocketed by 224.44% to $438000.0 in 2023, then increased by 2.97% to $451000.0 in 2024, then soared by 659.65% to $3.4 million in 2025.
- Its Current Taxes stands at $3.4 million for Q3 2025, versus $715000.0 for Q2 2025 and $1.2 million for Q1 2025.